Description
Tirzepatide RDT’s are a compounded rapid dissolve tablet formulation of tirzepatide that dissolves rapidly under the tongue without the need for water. The medication is available exclusively pursuant to a patient-specific prescription based on the prescribing healthcare provider’s determination of individual patient need. Compounded medications are not FDA-approved medications, and FDA does not review compounded medications for safety or efficacy.
The formulation process involves careful consideration of various factors including dosage precision, stability parameters, and patient-specific considerations. Each tablet is formulated to ensure rapid disintegration while maintaining the stability and potency of the active pharmaceutical ingredient throughout its designated beyond-use date.
The oral disintegrating technology employed in this formulation ensures that the medication begins dissolving immediately upon contact with saliva.
The compounding process for Tirzepatide ODT employs pharmaceutical techniques to ensure uniform distribution of the active ingredient throughout each tablet while maintaining the rapid disintegration properties of the formulation. The formulation incorporates specialized excipients that facilitate quick dissolution while protecting the stability of tirzepatide during storage and handling.
There are no reviews yet.